PainX combines Meta Mag magnesium and Levagen+™ PEA to provide enhanced pain relief and muscle relaxation. This dual-action approach targets both neuromuscular pain and inflammation.
Mechanism of Action:
Magnesium:
Muscle Relaxation: Magnesium prevents muscle spasms by blocking calcium ion entry in synaptic nerve terminals and inhibiting presynaptic acetylcholine release.
Glutamate Antagonist: As a natural glutamate antagonist, magnesium helps reduce central sensitization and pain amplification.
Protective Effect: Higher magnesium intake is associated with a reduced risk of chronic pain. PainX contains 420mg/day to help meet the recommended daily intake.
Palmitoylethanolamide (PEA):
Endocannabinoid System Support: PEA enhances the activity of cannabinoid receptors (CB1 and CB2) involved in modulating inflammatory responses and reducing pain perception.
Efficacy in Nerve Pain: Clinical trials show significant pain reduction in nerve compression syndromes, such as sciatic pain.
Enhanced Bioavailability:
Meta Mag®: This unique form of magnesium is covalently bound to glycine, ensuring superior absorption and effectiveness compared to other magnesium forms.
Levagen+™ PEA: utilising LipiSperse technology, Levagen+™ PEA demonstrates 70% greater absorption and prolonged plasma presence, equating to the efficacy of a higher dose of standard PEA.
Applications:
• Reduces and relieves nerve pain and persistent muscular pain, cramps, and spasm.
• For neuromuscular pain, such as shoulder and back pain, head and neck pain, sciatic pain, and fibromyalgia pain.
• PEA is analgesic and anti-inflammatory, exerts endocannabinoid activity and reduces pain amplification and muscle pain.
• Contains highly bioavailable PEA and exclusive Meta Mag Magnesium.
PainX offers a robust option for managing neuromuscular pain, leveraging enhanced bioavailability of magnesium and PEA for superior clinical outcomes.
